New E-Learning Program Cuts Teen Drug Use by Up to 75%

News by CISION
Aug.05.2022
The e-learning program is fun, engaging, and easily accessed with digital devices routinely used by today's teens. Class sessions to practice the skills taught in the program were also included.

Results of a study just published in Frontiers in Digital Health, an international scientific journal, show that teen drug use can be cut dramatically using a newly developed e-learning program that is fun, engaging, and easily accessed with digital devices routinely used by today's teens. Class sessions to practice the skills taught in the program were also included.

 

The e-learning program is a digital version of the Botvin Life Skills Training (LST) program and is designed to provide middle school students with the knowledge and skills needed to promote health, wellness, and resilience. LST has been extensively tested and proven effective through research published in over 30 scientific papers. The study published today is the first to prove the effectiveness of the new e-learning adaptation of LST. It also provides evidence that a hybrid digital program is effective when self-paced e-learning modules and teacher-led class sessions are combined.

 

The current study included 1,447 students from 23 middle schools across the United States. Schools were randomly assigned to receive the e-learning program and class sessions or serve as a "treatment-as-usual" control group. Compared to controls, students who received the e-learning program and class sessions showed significantly less cigarette smoking, e-cigarette and vaping use, excess alcohol use, marijuana use, and prescription drug misuse. They also showed increased health knowledge and skills knowledge, increased decision-making skills, increased skills related to coping with anxiety and anger, more effective communication and social skills, and increased conflict resolution and assertiveness skills.

 

"These are very exciting findings," said Dr. Gilbert J. Botvin, professor emeritus at Cornell University's Weill Medical College and developer of the LST program. "As access to new technology becomes more available, it is important that we utilize that technology to meet the health needs of schools, families, and communities."

 

The new hybrid digital version of LST was developed by National Health Promotion Associates (NHPA) and tested by a team of researchers led by Dr. Kenneth Griffin, a professor of global and community health at George Mason University, and Dr. Christopher Williams, director of research at NHPA and adjunct associate professor of psychology at Purchase College, State University of New York.

*The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the original author and refrain from forwarding directly from here.

UK Releases Latest Approved E-cigarette List: 227 New SKUs Cleared, Including ELFBAR, LOST MARY, and VAPORESSO
UK Releases Latest Approved E-cigarette List: 227 New SKUs Cleared, Including ELFBAR, LOST MARY, and VAPORESSO
Between July 19 and 28, the UK Medicines and Healthcare products Regulatory Agency (MHRA) published 227 SKUs in its e-cigarette product notification database, including updates on high-puff devices, refillable pods, and multi-flavor cartridges from brands such as ELFBAR, LOST MARY, and VAPORESSO.
Jul.28 by 2FIRSTS.ai
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Since April 2024, Singapore’s Health Sciences Authority (HSA) has shut down over 600 Telegram groups promoting or selling e-cigarettes and Kpods. This is the first time HSA has released such data. Additionally, from January 2024 to March 2025, HSA and the Ministry of Health removed more than 6,800 online listings related to e-cigarettes—more than double the number removed in 2023.
Jul.17 by 2FIRSTS.ai
STMA Launches Special Inspection: Shenzhen Vape Companies Face Major License Renewal Test
STMA Launches Special Inspection: Shenzhen Vape Companies Face Major License Renewal Test
Shenzhen office of the State Tobacco Monopoly Administration (STMA) announced the launch of a month-long special inspection targeting local vape companies.
Jun.12
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
Malawi relies heavily on tobacco, which generates over 50% of foreign exchange and 12% of GDP. In 2025, output is expected to reach 175 million kg, but lower prices and rising costs hurt profits. TAMA CEO Nixon Lita discusses climate effects, market pressures, diversification, and challenges from next-generation nicotine products.
Jul.30
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs said its e-cigarettes have received FDA marketing granted orders (MGOs), meeting the “public health” standard. It noted it is the only major vaping firm not backed by a traditional tobacco company.
Jul.18
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. tobacco maker Cabbacis has secured a USPTO patent (No. 12,349,724) for oral vaporizer pods, effective until July 2038. With existing patents, its iBlend™ harm-reduction products—featuring low-nicotine and hemp blends—are now protected in over 30 countries and key global tobacco markets.
Jul.18 by 2FIRSTS.ai